Evidence map›Paper›PMID 23437435›Full record

ArticleChemical communications (Cambridge, England)2013

A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disorders.

Kimberly M Lincoln, Paulina Gonzalez, Timothy E Richardson, David A Julovich, Ryker Saunders, James W Simpkins, Kayla N Green

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. TargetingMetabolites · 2026
    Article
  4. Article
  5. Predicting pRSC advances · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kimberly M LincolnDepartment of Chemistry, Texas Christian University, 2800 S. University, Ft. Worth, USA.
Paulina Gonzalez
Timothy E Richardson
David A Julovich
Ryker Saunders
James W Simpkins
Kayla N Green
Texas Christian University · USUniversity of North Texas Health Science Center · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
Protein Targets of Oxidative Brain AgingP01AG022550 · NIA · WEST VIRGINIA UNIVERSITY · PI SIMPKINS, JAMES W. · 2003 to 2013
$15.7M
ROLE OF MITHOCHONDRIAL ERB IN NEURONAL VULNDERABILITY TO NEUROTOXIC STRESSP01AG027956 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI SINGH, MEHARVAN · 2007 to 2017
$11.3M
Training in the Neurobiology of Aging and Alzheimer's DiseaseT32AG020494 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ROBERT Clinton BARBER, NATHALIE SUMIEN · 2002 to 2026
$6.9M
NIA NIH HHS P01 AG022550NIA NIH HHS P01 AG027956NIA NIH HHS T32 AG020494NIGMS NIH HHS U54 GM104942PHS HHS P01 AGAG027956
6 · The paper itself

Abstract

Metal-ion misregulation and oxidative stress have been linked to the progressive neurological decline associated with multiple neurodegenerative disorders. Transition metal-mediated oxidation of biomolecules via Fenton chemical reactions plays a role in disease progression. Herein we report the synthesis, characterization and antioxidant activity of 2; a pyclen derivative with enhanced antioxidant character.

Indexed as

AntioxidantsAzabicyclo CompoundsCell DeathCells, CulturedCell SurvivalDose-Response Relationship, DrugHumansModels, MolecularMolecular StructureMolecular WeightNeurodegenerative DiseasesOrganometallic CompoundsOxidation-ReductionOxidative StressReactive Oxygen SpeciesStructure-Activity RelationshipAntioxidantsAzabicyclo CompoundsOrganometallic CompoundspyclenReactive Oxygen SpeciesTransition Elements

Identifiers

PMID23437435
PMCPMC4446701
OpenAlexW4233606408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.